JAK inhibitors in patients with high cardiovascular risk – pro et contra

Radiž, Mislav

doi:10.33004/reumatizam-supp-72-1-25

Reumatizam, Vol. 72 No. Supp 1, 2025.

Sažetak sa skupa

https://doi.org/10.33004/reumatizam-supp-72-1-25

JAK inhibitors in patients with high cardiovascular risk – pro et contra

Mislav Radiž *

* Dopisni autor.

Puni tekst: hrvatski pdf 653 Kb

str. 35-35

preuzimanja: 126

citiraj

APA 6th Edition

Radiž, M. (2025). JAK inhibitors in patients with high cardiovascular risk – pro et contra. Reumatizam, 72 (Supp 1), 35-35. https://doi.org/10.33004/reumatizam-supp-72-1-25

MLA 8th Edition

Radiž, Mislav. "JAK inhibitors in patients with high cardiovascular risk – pro et contra." Reumatizam, vol. 72, br. Supp 1, 2025, str. 35-35. https://doi.org/10.33004/reumatizam-supp-72-1-25. Citirano 14.08.2026.

Chicago 17th Edition

Radiž, Mislav. "JAK inhibitors in patients with high cardiovascular risk – pro et contra." Reumatizam 72, br. Supp 1 (2025): 35-35. https://doi.org/10.33004/reumatizam-supp-72-1-25

Harvard

Radiž, M. (2025). 'JAK inhibitors in patients with high cardiovascular risk – pro et contra', Reumatizam, 72(Supp 1), str. 35-35. https://doi.org/10.33004/reumatizam-supp-72-1-25

Vancouver

Radiž M. JAK inhibitors in patients with high cardiovascular risk – pro et contra. Reumatizam [Internet]. 2025 [pristupljeno 14.08.2026.];72(Supp 1):35-35. https://doi.org/10.33004/reumatizam-supp-72-1-25

IEEE

M. Radiž, "JAK inhibitors in patients with high cardiovascular risk – pro et contra", Reumatizam, vol.72, br. Supp 1, str. 35-35, 2025. [Online]. https://doi.org/10.33004/reumatizam-supp-72-1-25

Sažetak

Ključne riječi

Hrčak ID:

339530

URI

https://hrcak.srce.hr/339530

Datum izdavanja:

5.11.2025.

Podaci na drugim jezicima: hrvatski

Posjeta: 415 *

Prijava i registracija

Reumatizam, Vol. 72 No. Supp 1, 2025.

Sažetak

Ključne riječi

Hrčak ID:

URI

Datum izdavanja: